Mon, Oct 20, 2014, 10:40 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

BioLife Solutions, Inc. Message Board

  • googenheim2 googenheim2 Aug 29, 2013 10:37 AM Flag

    Potential Reverse Split

    I expect an issuance of new shares in conjunction with a reverse split to happen prior to the end of the year.
    The risks entailed in both appear to be offset by the benefits that will accrue...the likely reduction of debt and Nasdaq listing. Reverse splits are often identified with floundering companies taking drastic action in the
    face of a host of difficulties...a way to prop up stock price and to remain relevant at a time of corporate stress.
    This is not the case at all with BLFS. In fact it's quite the opposite...BLFS is expanding and setting the operational stage for a high growth future.

    A clue to the reverse split liklihood is the recent appointment of Robert Preti, Ph.D, to the Biolife Solution's Scientific Advisory Board. Mr. Preti is the President and Chief Scientific Officer of Progenitor Cell Therapy, a subsidiary of Neostem (stock symbol NBS) which executed a 1 for 10 reverse split in July (last month), the very month in which Mr. Preti was appointed to the Scientific Advisory Board. Perhaps only a coincidence.
    By the way the price of NBS ( which has a market cap approx. 2.5 times that of BLFS) has stabilized in the mid-7 dollar range since the time of the reverse split. NBS is also a stock that should be considered for purchase and has a number of Seeking Alpha articles just in the last month. You could look it up.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • we had a reverse split years ago and it was a disaster

      • 1 Reply to wsj111
      • BLFS has risen by a factor of 10 in less than one year. The business acumen of current management is extraordinary for such a relatively small company. Perhaps "reverse-stock splits" are inherently dangerous. I don't know. But I believe
        BLFS has a cutting-edge product, a niche product that is fundamental to a wide spectrum of firms in an industry that is experiencing phenominal growth. The risk is in management execution and the potential of a compelling competing product. I will hold my breath if BLFS announces a stock offering and a reverse-stock split. But I tend to hold my breath at one time or another on most of the stocks I own. I believe BLFS will be up by a factor of 10 again within 2 years reverse-split or not.

 
BLFS
2.080.00(0.00%)Oct 20 3:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.